These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1937541)
21. [Immunogenic properties of recombinant vaccinia virus containing the human IL-2 gene]. Babkin IV; Riazankin IA; Lebedev LR; Bulychev LE; Nesterov AE; Nosareva OV; Babkina IN Vopr Virusol; 2008; 53(1):27-31. PubMed ID: 18318132 [TBL] [Abstract][Full Text] [Related]
22. Cutting edge: Enhanced IL-2 signaling can convert self-specific T cell response from tolerance to autoimmunity. Waithman J; Gebhardt T; Davey GM; Heath WR; Carbone FR J Immunol; 2008 May; 180(9):5789-93. PubMed ID: 18424696 [TBL] [Abstract][Full Text] [Related]
23. Interleukin-2, a pro-autoimmune lymphokine that interferes with post-deletional tolerance. Kroemer G; Martínez C Semin Immunol; 1992 Jun; 4(3):167-79. PubMed ID: 1627788 [TBL] [Abstract][Full Text] [Related]
24. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. Rangachari M; Mauermann N; Marty RR; Dirnhofer S; Kurrer MO; Komnenovic V; Penninger JM; Eriksson U J Exp Med; 2006 Aug; 203(8):2009-19. PubMed ID: 16880257 [TBL] [Abstract][Full Text] [Related]
25. Hypo-active variant of IL-2 and associated decreased T cell activation contribute to impaired apoptosis in autoimmune prone MRL mice. Choi Y; Simon-Stoos K; Puck JM Eur J Immunol; 2002 Mar; 32(3):677-85. PubMed ID: 11857342 [TBL] [Abstract][Full Text] [Related]
26. Hypothesis: A recurrent, moderate activation fosters systemic autoimmunity--the apoptotic roles of TCR, IL-2 and Fas ligand. Matsui K; Jodo S; Xiao S; Ju ST J Biomed Sci; 1999; 6(5):306-13. PubMed ID: 10494037 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-2. Smith KA Sci Am; 1990 Mar; 262(3):50-7. PubMed ID: 2315671 [No Abstract] [Full Text] [Related]
28. Local transgenic expression of granulocyte macrophage-colony stimulating factor initiates autoimmunity. Biondo M; Nasa Z; Marshall A; Toh BH; Alderuccio F J Immunol; 2001 Feb; 166(3):2090-9. PubMed ID: 11160260 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-2 in autoimmunity: on records, hypotheses, theories, and facts. Alarcón-Segovia D J Rheumatol; 1983 Feb; 10(1):159-60. PubMed ID: 6601711 [No Abstract] [Full Text] [Related]
30. [Suppressor T-cells: immunologic regulator cells and clinical perspectives]. Neumann-Haefelin C; Spangenberg HC; Thimme R; Blum HE Dtsch Med Wochenschr; 2004 Jul; 129(30):1627-30. PubMed ID: 15257502 [TBL] [Abstract][Full Text] [Related]
31. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Ramshaw IA; Andrew ME; Phillips SM; Boyle DB; Coupar BE Nature; 1987 Oct 8-14; 329(6139):545-6. PubMed ID: 3498904 [TBL] [Abstract][Full Text] [Related]
32. [Role of interleukins in autoimmunity]. Fradelizi D; Harel-Bellan A; Chatenoud L Presse Med; 1984 Mar; 13(12):713-5. PubMed ID: 6231574 [No Abstract] [Full Text] [Related]
33. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Coutinho A; Caramalho I; Seixas E; Demengeot J Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475 [TBL] [Abstract][Full Text] [Related]
34. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma. Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469 [TBL] [Abstract][Full Text] [Related]
35. The interleukin-2 inhibitors and their role in low-toxicity regimens. Nashan B Transplant Proc; 1999 Dec; 31(8A):23S-26S. PubMed ID: 10616557 [No Abstract] [Full Text] [Related]
36. Interleukins and the immune system 1. O'Garra A Lancet; 1989 Apr; 1(8644):943-7. PubMed ID: 2565429 [No Abstract] [Full Text] [Related]
37. Induction of anergy by antibody blockade of TCR in myelin oligodendrocyte glycoprotein-specific cells. Wasserman HA; Evavold BD J Immunol; 2008 Jun; 180(11):7259-64. PubMed ID: 18490725 [TBL] [Abstract][Full Text] [Related]
38. Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation. Mukherjee S; Haenel T; Himbeck R; Scott B; Ramshaw I; Lake RA; Harnett G; Phillips P; Morey S; Smith D; Davidson JA; Musk AW; Robinson B Cancer Gene Ther; 2000 May; 7(5):663-70. PubMed ID: 10830713 [TBL] [Abstract][Full Text] [Related]